AI Verdict
IOTR has stronger fundamentals based on our AI analysis.
IOTR vs IONS Fundamental Comparison
| Metric | IOTR | IONS |
|---|---|---|
| Revenue | N/A | $203.3M |
| Net Income | N/A | $-381.4M |
| Net Margin | N/A | -187.6% |
| ROE | N/A | -78.0% |
| ROA | N/A | -10.8% |
| Current Ratio | N/A | 3.83x |
| Debt/Equity | N/A | 3.71x |
| EPS | N/A | $-2.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOTR vs IONS: Frequently Asked Questions
Is IOTR or IONS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IOTR has stronger fundamentals. IOTR is rated HOLD (5% confidence) while IONS is rated SELL (85% confidence). This is not investment advice.
How does IOTR compare to IONS fundamentally?
iOThree Ltd has ROE of N/A vs IONIS PHARMACEUTICALS INC's -78.0%. Net margins are N/A vs -187.6% respectively.
Which stock pays higher dividends, IOTR or IONS?
IOTR has a dividend yield of N/A or no dividend while IONS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOTR or IONS for long term?
For long-term investing, consider that IOTR has HOLD rating with 5% confidence, while IONS has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOTR vs IONS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOTR vs IONS, the AI consensus favors IOTR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.